Treatment of neurocysticercosis: current status and future research needs
T E Nash, G Singh, A C White, V Rajshekhar, J A Loeb, J V Proaño, O M Takayanagui, A E Gonzalez, J A Butman, C DeGiorgio, O H Del Brutto, A Delgado-Escueta, C A W Evans, R H Gilman, S M Martinez, M T Medina, E J Pretell, J Teale, H H Garcia, T E Nash, G Singh, A C White, V Rajshekhar, J A Loeb, J V Proaño, O M Takayanagui, A E Gonzalez, J A Butman, C DeGiorgio, O H Del Brutto, A Delgado-Escueta, C A W Evans, R H Gilman, S M Martinez, M T Medina, E J Pretell, J Teale, H H Garcia
Abstract
Here we put forward a roadmap that summarizes important questions that need to be answered to determine more effective and safer treatments. A key concept in management of neurocysticercosis is the understanding that infection and disease due to neurocysticercosis are variable and thus different clinical approaches and treatments are required. Despite recent advances, treatments remain either suboptimal or based on poorly controlled or anecdotal experience. A better understanding of basic pathophysiologic mechanisms including parasite survival and evolution, nature of the inflammatory response, and the genesis of seizures, epilepsy, and mechanisms of anthelmintic action should lead to improved therapies.
Figures
Source: PubMed